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~ Lipid Levels, Adherence to Medlcltlon, Ba~llno 
Chma~erlatics In the Cholesterol and RKur~ent 
Evtmts (CARE) Study 
J ,MO, Am~l ,  BR O~v=~, DT, Nard, W- InPut, d~, S Lewd, RM K~hn, 
SP- Gl~_s~, KM 0¢~w, B, Kimmct, F,M, ~¢k~ LH~-C, LOn~, ON. 
~ k ~  ~ Uti,~ati¢~ ot ~ ~l(~ln¢~¢P,~O tO lilL~! ~we~¢qng treatment fem~!n 
k~v in th# cg~.~m~ty. In ~f f~st ,  in the_ l~ l  y~af Of Io!~w=L~ of 41~,9 
pat~nt~ in CARI~, the ¢(~tm~t~gn Fdte to{ t~nt~l s_t~t me.L/~tion w~, ~6% 
in p!~_abO (pL_) ~ln~l {]4% in the ~gf~v~t~tin (PRA) g to~ ar~l the~=~ I ti~nt~ 
R~,~P~-- In I t~  pattCrtts wit~ an MI ~ "ave3~g~" CbetOSter01 k~vels, 
PRA eL~l~,3Nly riL~d~¢e~ Li~=. cho~_~terol We_is ~ the pnmal~ enq~ird, 
ratA! O0,t'~m~P/W~I Or ~, f~ta l  MI, by 24% TLe#iment L_DL levels were 
tit~ was - 41 mahdi in tl'~_ PRA _~rctJ~ ~ 2 n~Jd! in tho IPL ~m~.  The5 
LDL Ch~ w~S !m~ady ¢ofle__lat _ed with ~it~rence in the PRA grc=up (p 
0.0001) reP{e.,c,~nting # 0,.5 m~dt c~_ reas~ in LDL f0r each t% in, Czease in 
ac~rEm~e. A(~ml~e w"d,~  5am~ in each treatment gre~ and remained 
s t~e over the m~J~n ~Ik~ ~p of 5 yem~, U~ng a 5tepwise regressmn 
ra,~je!, befter adherence to sLudy m¢-d~atm, n was related to race (white) p 
* OOQOt, not being a cuneof s m.aker p < 0.0001, sex (female) p - 003, 
and rot being empleyecl p < 004 Ce~n baseline ¢l~ractensr~cs including 
education, cat ty  with d~al~!~.~ Of hype~tensma, and bO(~y mass index 
did not cometate sicjnifican~ with edt'~, rence. 
Conclusions: Thus, PRA was well t~eraled in CARE. ac~nerance to as- 
signed trealment remmnecl h~gh dunng active pat]ant follow-up in th~s clinical 
mat, and adherence was correlated with improved reduclmns in ~L  lev- 
els A~rence  lo treatment was related most strongly to racu and srn~lung 
status 
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• As~iated Risk Factors do Not Prevent the 
Beneficial Effect of Aggressive Cholesterol 
Lowering: Post CABG Trial 
L. Campeau, G. Knatteeud, D. Hunmnghake, M. Domanstu, C. White, 
J. Canner, J. Fonester, N. Geller, F Gobel, JA.  Herd, B. Heogwerf, 
Y. Rosenberg. Montreal Hear Instffute. Montreal, Quebec. Canada 
Background: The Post CABG trial (N Engl J Mad 1997; 336: 153-162) 
showed in 1351 patients that an aggressive LDL-cholesteml lowering (AL) 
to 93-97 mcj/dl dunng 4.3 years parted compared to a mederate Iowenng 
(ML) to 132-136 mg~dl significantly delayed progression of atheresclero~is 
(lumen reduction ",0.6 nun) in saphenous vein grafts placed t to I1 years 
previously (27% vs 39%: p < 0.001). 
Methods: Using a graft-based analysis (generalized estimating equabon 
model), the probabilities of progression (Prog) were obteinud for both groups, 
AL and ML  The following risk factors (RF) were considered: smoking, alia- 
bales mellitus, hypertension, HDL-cholesterol ,:40 mcj/dl, thglycendes < 145 
mg/dl, and the number o! RF. 
Results: The same beneficial effect is observed as judged by a similar 
significant nsk ratio (0.5 to 0.6), and no interaction between subeategones 
of RF. Detailed analyses of the number of nsk factors are shown in the table 
below. 
NO RF Preg. t%) P value RR (95== CI) 
AL ML 
0-1 274 32 5 0 12 0.78 (058-1 06) 
2 263 43,6 .0,0001 8.46 (032-0,66) 
-3 29.8 46.6 00001 0.49 (0 34-070) 
Conclusion: LDL-cholesterol lowering to 95 mg/dl compared to 135 mgJdl 
delayed saphenous vein graft atheroscleresis to the same degree in palrents 
with or without associated risk factors. 
5:00 
~5-]  Does the Presence of Certain Cardiac Risk  Factors  
Posi t ive ly  In f luence  R isk  Factor  In tervent ions?  
S. Mora, RS. Stafford, R.E. Chaput, T. Bishop, R.C Pastemak. 
Massachusetts General Hospital Boston, MA, USA 
Screening and treatment of cardiac risk factors (RF) by physicians remains 
suboptimal. We explored the association between RF intervention and pa- 
tient (pt) characteristics to identify predictors of risk factor interventions. A 
cross-sectional survey of 234 outpatients in a cardiology practice over 6 
m~eths ( t~ ~7l w~, un~rb~kcn PtS chn~C~! ¢.¢r~t~o~ nay factors ~r~ 
~ntorvcntL~rLs ~.Ao~rr~l (;t~nn 0 the vi~t~, wcr¢ ~tr(~(,lecl tror~ fits fT~!  
racer0, Pot~n~l Confoge(~:~cr,~ wig.f0 co~tfotle0 t~r uSm 0 Io~s~ r i~S~0n 
tO ~terr~ne the mdepef~_:nt !~k¢flh0,0~ of n~k f~_¢tCf mtr;rvent~o,"~ ~tend, 
vt_~,U'_¢31 ¥isJts Of ~3,4 ~t W~.|Ls, I~lO0~ pre~ut~ (0P) ~¢mef f f  W_~ r@ 
• ¢t i~s_s_e.~_~m~_nt~ i  43%,, ~P,(I ~t  ¢O~ft~JiP, 0 in -24%, PI~= with-h~ cr~l 
testin 9 (OR 110, 4,~--~,~), ~e.t ae~¢nf~ (OR 3,6, 10=7-2) ~ ~e_t 
b~t not OP ot Chef m~iur¢t,~__ntP, O i~ l~ I~s w#r~ Oflly mo~'e likely In 
havo deer a s_scspm~fits (OR ~,9, 1 r~,5)  , Hyp#rten~w¢ ~ r~etv~l I¢~,~ 
dt¢! counseling (OR 0.37, O-2--0 9) Ago and sex h~d no efl_e¢_t On in~rveno 
ti0ns 
Co~/ t~on Physicians more ag~l~ess~vely intcn/en~d with t~--¢ and 
hyp~rchol _e.~,tcr¢m~¢ pt_s ¢orr~,~fe~ |O hylL~itenSlv@ Of ~,Td~r=t~c. el.s, Ri~k fa_ctor 
¢0nft0| may be_ lm~mved bY recognizing thC=l Certain P~_setiP~ e~k fac l~ 
barn~r~ to lnt¢~¢ntion 
5;15 
E.ect ot p!a...om=y=t(e)l.e L l= o .  
Cardiov_ascu!ar Outcomes A~r PTCA or CABG In 
EAST 
X-Q. Zha.o, AS. Kosm~ki, MR Malffmw, HX Bamhaft, J.W D~vis, 
BG. Brown. S-B. King, I Un~v o! Washington. _Seattle. WA an¢l Ernoq/ 
Urw.. At/anta, GA. USA 
Background:The p f~_~ic  value of hemocyst(e)ine (H (e)) levels in coronary 
artery dJs~a3e (CAD) patients (pts) receiving PTCA or CABG was exan~necJ 
in the Emo~ Ang~opfasty vs  Surgery Thai (EAST). 
Me~:  Of 392 m~ltlvassel d~sease pts who were randomized to an initia! 
strategy of PTCA or CABG, 295 had at least one H(e~ level measured dunng 
the first 3 yre (~t he study. The mean H(e) level was 12.8 ± 5.2 .molJL and 
was not different between PTCA and CABG pts, The pts were followed for 
any adverse can~ovasCUlar outcomes (ACVO) including death, myocardial 
infarction (MI), stroke and addibonal revasculanzation procedure(s) (PTCA 
or CABG) (AddPro) for 5 yrs after the initial PTCA or CABG. e l  295 pts, 27 
died. 55 sulferc--cl non-fatal ML 18 had stroke and 114 expanenced AdclPre. 
The mean H(e) level was compared between pts with and without ACVO, 
and the % of pls with ACVO wthin 5 yrs was computed for each H(e) quadile 
(Q) The QI is H(e) <9 7, the Q2 is ~_9.7 and ~ 117, the Q3 =s ~117 and 
14.7, and the Q4 is : 14 7 i,mol/L, respectively, 
Results. 
H(e) and adverse ca)'d~ovascutar ouTo3rnes 
Mean H(e)'i, moEL % 0tp~ m 
Q! Q2 Q3 Q4 
Deah .35 T 7 15 30 4B t 
MI'" *0 3 25 29 24 22 
Stmke 09 22 33 33 12 
AddPro 02 26 26 24 24 
• the dttference ~n H(e) betv~een pts wiIrl and ~,~IhQut the adverse cardiovascular md- 
cl3mes: r: p . oool: ~; p 001; "" nGn-iafalMI 
Concluszons: In EAST. Hie) levels are a strong and graded predictor 
of modality in CAD pte following PTCA or CABG. However. H(e) levels 
did not predict future non-iatal myocardial infarction, stroke or adcStionnl 
revasculanzalion procedure(s) after initial PTCA or CABG Clinical trials wLth 
H(e)-Iowering therapy appear to be indicated, 
Autonomic/Hormonal Modulation of 
Arrhythmias 
Monday, March 30, 1998, 4:00 p.m.-5:30 p.m. 
Georgia World Congress Center. Room 257W 
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F~-~ Cerebral Vasoconstriction Occurs Prior to Systemic 
Vasodilatation in Neurocardiogenic Syncope 
D. Dan. J.B. Hoag, K.A. Ellenbogen, D.L Eckberg. D.M Gilh,.jan. Medical 
College of Virginia and McGuire VA Medical Center. Richmond. VA. USA 
Cerebral blood flow (CBF) may be affected in patients with neurecardio- 
genie syncope due to an abnormal neural reflex. We hypothesized that 
cerebral hemodynamics change independently from systemic vasoddata- 
tion. The mean ar?en~ pressure (MAP with Finapr'csl and CBF velOCities 
90A ,%II,',;TI~,ACI'~ Or;d ],\(,(" I:chru~tr.~ I ,~)}~ 
(trenscranlol Doppler) woro continuously recorded in 15 ~ubjects undergoing 
tilt labia to~ting lor ovak~0tion of sync0po, Th0, pulsatlllty index (PI = (Vm,=, 
V,.,.)N,.,,,.) and the CBF velocity corrected tot Iteart rote (CBFV, = velocity 
mtogral/provloug RR interval) wore plotted against lime, 
Re,~ults: Fight man I~od positive tilt rocpongo[~ (55 ,  11 yrs) and 7 pallonls 
(6 men, 1 womsn. 45 t. 9 yr8), had n0gative responses, Tl~o last 4 minute of 
herr¢odyn[tmic recordings ore displayed In tl~e Figure. At time "0" in the Till(+) 
g~oup tit0 lowest MAP was recorded. The ro{ItJctlon in CI~FV,: occurred arrd 
w,~ greatest prior to II~o MAP loll In the Till(*) pottont~, The toll in CLaFV~ 
bogcm prior to that of the MAP (breakpoint analysis), The.] was no clr0ngo 
in CI3FV in th0 Till( ) ~ubj0c(~, 
r~lll rill( I 
Cenclusioa,,~ In TIII(~) ~|lblUCts C[~FV ttlflltll ttllllng bolole MAP, 5UggOSl- 
Ifl o that the triggering event m syncope vn[ty ba cenlral, and lh¢d tilt) syslem=c 
v~5odilr~f~tion OCcuca I~tter 
4:15 
. , .  course of . . r ,  Rs,o o.d .ear, Ro,o ,,ar,ab,,,,y 
~'~ Before Spontaneous ~ustalnad Ventrlcular 
'll~chyeardla 
K.P, Anderson, V. Shusferman, El. Ay~in, S ~odo, V Gon=paty, 
O, Schwadzman. For fire ESVEM Invesfigafor~, University of Pittsb~ugh, 
P~ffsburgh, PA, USA 
Alterations in autonomic nervous ~ystem activity (ANSA) padicipatn ~n m- 
rhythmegenos+s but little informatio~ o}(ists on the time course el Such effects 
TO address the hypothesis that e window el oppodunity exists during which 
preventive Interventions could be employed, we examined the changes in 
heart rote (HR) and HR variability indices (HRVi), which reflect ANSA, prior 
to the onset of spontaneous sustained monomorphic vontncular taehycardia 
(VT.~,,,,). 
Methods: Hotter ECGs with VT~,.. recorded from 40 pahents (pts) in the 
absence of anliardrythmic drugs were analyzed, Power m yon/ low (VLF 
00033-004 Hz), low (LF: 004-0,15 Hz) ~nd high (HF: 015-O4 H~) fre- 
quency ranges and Iotal power (TP) wore estimated in 5 and 15 m=n segments 
over the 24 hr period and Iogaritl~mtcally tranSform0d, 
Results: Mean HR rose gradual!y bolwocn 3 and 2 hr, thee accelerated t 
hr before MT~.~., The mean rates of decline in RR interval at 3 hi, 2 br, 1 hr, 
30 rain and 15 rain before VT~.~., wore, respectively, 0164 * 1.187, 0.062 
t 0,988, 110 , 2.23, 1,B6 * 5.22 and 1.85 * 4.9g ms/min. HR was higher 
1-2 hr before the onset of VT~,~,,, compared to 3 I~r in 31 pts (65%), HR began 
to rise in 32% el these pts at 2 hr. in 16% each at 60. 45, and 30 min, and in 
20% at 15 rain. Changes in HRVi began between 2 and 1 hr with the most 
prominent changes 30 rain before VT~,. compared to averages over 24 hr 
(VLF: from 6,49 ~ 1,301o6.18 t 1,021nnrs:.p =0.037, LF: from 5,43 t 
1.35 to 5,14 ~ 1,46 In ms;', p = 0,004, HF: from 4.64 ~ 0.99 to 4.45 .. 1.20 
In ms;', p = 0,03, LF/HF: from 0.91 : 1 12 to 0.76 ~ 1.14, p = 0.011). 
ConckrSlons: Evidence of altered ANSA activity preceding VT,~., was 
detected i0 31t48 (6500) of the pts. A time period between the onset of 
delectable HR and HRVi indicators of ANSA of at least 15 min was present in 
B0% Of 31 pts. and in 3~% a time window :-60 min was present. Preventive 
interventions may be feasible in subsets of pts with VT~.  
4:30 
~3-3  Sinus Cycle Shortening During Ventrieular 
Tachycardia Predicts Better Than Ventricular 
Funct ion Major  Events in the Fo l low-up  
M I.andolina. G.M. De Ferrari, M. Mant~a. R. Manfredini, P.D. 3ella, 
A. Vincenti, S. Remano Oept of Cardiology, IRCCS Osp Maggiore and 
Centre F~siolog~a Chn~ca. University el Milano, Mtlano. Italy 
Sinus node (SN.) reflex response during induced ventricular tachycardia 
(VT) is likely to be related to autonomic reflex modulation and may therefore 
provide prognostic information. 
This study assessed the prognost;c value of the percentage shortening 
of S.N cycle 30 s after the induction of VT with V-A dissociation, compared 
to the baseline valttes, in 50 pie rage 65 :t 8 years, LVEF 36 t 11%) with 
clinical suslolnod VT after myocardial infarction. 
Survival vs S.N. cycle shortening 
"°. F~..=~, . . . . .  
° t ,,t 20% 
Follow-up (mot~) 
Survival v8 LVEF 
1,0 ~'"1  
FOllOw-up (moo) 
DL!rmg a medi,~n fOllOw-Up of 16 months, 7 pts had ~ cardiac death and 2 I 
a VT recurrence Kaplnn.Mei0r event-boo survival c~Jlrv~s howe~ thai S IN  
cyclo shortening - P0% In ~ ~0) was associated with a slgnihcant|y incrg~s~d 
=ate el meier events, An impa!md LVEF l- 35%) (n =. 30) w~s a markedly 
pOorer predictor of nraior events. By multivanato analysis only SN. Cycle 
shortening was a significant independent predictor (p = 0 Q00I) 
Thus, ~ blunted SN response to VT is a marker el madequate autor~m~c 
m0dalahon that can earn/independent prognostic interm~t~on 
4:45 
F- - - _ I  .dro.ho.lum .yd.och,or,do Ms  .o, E,e.,o 
. . . . .  Ventrlcular Fibrillation Thresholds in Humans 
RD. M=frani. A. Intenan. Jr, J Dylewsk=, EM Kloosterman. S Atapattu 
L Munoz, A. Castellanos, R J Myerbufg t. aversity el M~ami School ot 
Medzcine, MlamL Florida. USA 
Intravenous phenylephrine levates vent0cular fibrillation (VF)thresholds m 
humans and animal models, presumably by bare(rex activation and reduced 
sympathetic activity. To determme whether direct vagomimelic activity u~mg 
edrophonium ted) has a similar effect, we studied 15 patients (mean age 60 
years) wilh ischemie and nonischemie cardiomyopathy dunng VF induction 
tVFI) as pad el dolibnllator Lmplantation or evaluation. Nine patients had VF 
reduced at baselme and alter Ed (10-15 rag) inlusion, while 6 patients se~ed 
as conhol and had 2 VFIs without Ed. The VIFI protocol was: T wave shocks 
(0.1-.4 joules) in a stepwise design. 10-30 msec alter, during or bolero the 
T wave peak. untd VF was induced. In the patients receiving Ed. the head 
rate decreased hem 72/minute at baseline to 67~minute IP = 0.07) while the 
control patients' head rate did not change (72 versus 711minute) between 
VFI 1 and 2 The number of attempts to induce VF on the 2 "~ versus 1 ~ 
attempt was not signilicantly different in the control patients (38 attempts for 
VFI 1 vs 22  attempts for VFI 2, p = 0.10) or in the group receiving Ed (34 
baseline vs 26  attempts with Ed. p = 034). Tire Q-T peak interval during 
ventneuler pacing did not vary with Ed. 
Conclusion, Edrophonium hydrochloride does not affect ventncular tibril- 
lotion induction m humans. The fact that increasing cardiac vogel activity by 
Ed does not increase VF thresholds suggests a direct role of sympathetic 
actwity rather than sympathetic/parasympathetic interaction. 
5:00 
~High  Efficacy of Steroid Treatment in Patients With 
Right Ventricular Outflow Tract Tachycardia 
I. Mendoza, F, Moleiro, J. Marques, A. Castellanos. F. Rodriguez, 
E. Troncoso, R. ReveI-Chion, A. Matheus, J. Guerrero, H. Acquatella. 
Central University el Wnezc~la. Caracas, Venezuela: University of Miami 
School of Medicine, Miami. Florida, USA 
Ob/ective: To evaluate the effects of steroid treatment on patients (pts) with 
.ght ventricular outflow tract ventdcular tachycardia (RVOT-VT). 
Background: The pathologic substrate of RVOT-VT is difficult to ascedain. 
The use of codicosteroids in RVOT-VT has not been evaluated. 
Methods: A series of 14 consecutive pts (10 temales and 4 males). Ages: 
41 ~ 14 years (range 20-65 years) with symptomatic RVOT-VT were ad- 
mitted to the study, Eleven had nonsustained VT and 3 sustained VT. Pts 
